RxDoctor Payments Data

Gregory Lewis, MD

Clinical Cardiac Electrophysiology · Hinsdale, ILNPI 1104864321

Payments from drug & device makers

$1,417in general payments, 2019–2025

Across 69 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$306
  • Edwards Lifesciences$261
  • Boehringer Ingelheim$198
  • Impulse Dynamics (USA) Inc.$153
  • Novartis$84
  • Coloplast$83
  • plus $331 from 12 others

What the payments were for

  • Food & beverage$1,31693%
  • Education$1027%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,417 in reported general payments places this provider in the 5th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

See all clinical cardiac electrophysiology providers in Illinois

Medicare billing

Part B allowed, 2024
$284,032
Medicare patients
1,720
Services billed
4,689

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban596$788,279
XareltoRivaroxaban147$191,404
JardianceEmpagliflozin101$128,846
EntrestoSacubitril/Valsartan100$126,422
MultaqDronedarone Hcl52$82,833
Repatha SureclickEvolocumab50$33,669
Ezetimibe744$20,590
BrilintaTicagrelor21$18,341
Rosuvastatin Calcium1,198$18,255
Flecainide Acetate292$13,239
Repatha SyringeEvolocumab11$10,263
Metoprolol Succinate489$6,365
Carvedilol389$4,026
Atorvastatin Calcium342$3,700
Amlodipine Besylate350$2,965

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$67$788,279596 claims
Johnson & JohnsonXarelto$306$191,404147 claims
Boehringer IngelheimJardiance$198$128,846101 claims
NovartisEntresto$84$126,422100 claims
Sanofi-aventis U.S. LLCMultaq$33$82,83352 claims
AstraZenecaBrilinta$14$18,34121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 5th percentile of 158 clinical cardiac electrophysiology providers in Illinois.

Other clinical cardiac electrophysiology in Hinsdale

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →